[1]刘 松,孟冉冉,张跃伟. 经肝动脉化疗栓塞与树突状细胞治疗肝癌对机体免疫功能的影响[J].介入放射学杂志,2014,(02):181-184.
 LIU Song,MENG Ran? ran,ZHANG Yue? wei.. TACE combined with dendritic cells for the treatment of hepatic cancers: its influence on patient’s immune function[J].journal interventional radiology,2014,(02):181-184.
点击复制

 经肝动脉化疗栓塞与树突状细胞治疗肝癌对机体免疫功能的影响 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2014年02期
页码:
181-184
栏目:
综 述
出版日期:
2014-02-28

文章信息/Info

Title:
 TACE combined with dendritic cells for the treatment of hepatic cancers: its influence on patient’s immune function
作者:
 刘 松 孟冉冉 张跃伟
Author(s):
 LIU Song MENG Ran?蛳 ran ZHANG Yue?蛳 wei.
 Department of Interventional Therapy, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China
关键词:
 【关键词】 肝动脉化疗栓塞术 树突状细胞 肝癌 免疫功能 研究进展
文献标志码:
A
摘要:
 【摘要】 肝动脉化疗栓塞术(TACE)已成为不能手术切除的中晚期肝细胞癌的首选疗法。树突状细胞(dendritic cells,DC)是目前已知功能最强大的专职抗原呈递细胞,在抗肿瘤免疫中起到关键作用。随着肿瘤介入及免疫治疗的发展,TACE联合DC治疗肝癌逐渐成为研究热点,研究证实两者联合治疗肝癌疗效显著,且对机体免疫功能有正向调节作用,展现了良好的前景。本文就TACE、DC及TACE联合DC治疗肝癌对机体免疫功能影响做一综述。

参考文献/References:

 [1] 赵广生, 张跃伟, 刘 影, 等. 新型明胶海绵微粒TACE治疗原发性肝癌术后致肝脓肿三例及文献复习[J]. 介入放射学杂志, 2013, 22: 415 ?蛳 417.
[2] 高 嵩, 朱 旭, 杨仁杰, 等. TACE联合奥沙利铂、氟尿嘧啶、 亚叶酸钙肝动脉化疗治疗中晚期原发性肝癌[J]. 介入放射学杂志, 2012, 21: 377 ?蛳 383.
[3] 杨 茂, 郭 志, 司同国, 等. 动脉化疗栓塞联合CIK细胞过继免疫治疗对中晚期肝癌患者免疫功能的影响[J]. 介入放射学杂志, 2011, 20: 116 ?蛳 119.
[4] Monjazeb AM, Hsiao HH, Sckisel GD, et al. The role of antigen?蛳 specific and non ?蛳 specific immunotherapy in the treatment of Cancer[J]. J Immunotoxicol, 2012, 9: 248 ?蛳 258.
[5] Vyas JM. The dendritic cell: the general of the army[J]. Virulence, 2012, 3: 601 ?蛳 602.
[6] Radford KJ, Caminschi I. New Generation of dendritic cell vaccines[J]. Hum Vaccin Immunother, 2013, 9: [Epub ahead of print].
[7] Hiroishi K, Eguchi J, Baba T, et al. Strong CD8(+) T?蛳 cell responses against tumor?蛳 associated antigens prolong the recurrence?蛳 free interval after tumor treatment in patients with hepatocellular carcinoma[J]. J Gastroenterol, 2010, 45: 451 ?蛳 458.
[8] Varga M, Valsanis A, Matia I, et al. Transarterial chemoembolization in hepatocellular carcinoma[J]. RozhI Chir, 2009, 88: 434 ?蛳 438.
[9] 王惠文, 刘瑞宝, 刘 岩, 等. 原发性肝癌TACE后FAK、 NF?蛳 κBp65表达及意义[J]. 介入放射学杂志, 2011, 20: 621 ?蛳 624.
[10] 刘晓芬, 宋 波, 纪雪红. 介入治疗对原发性肝癌患者T细胞亚群比例的影响[J]. 放射免疫学杂志, 2010, 23: 599 ?蛳 600.
[11] 韩亚琴, 鲁光平, 潘骥群, 等. 中晚期HCC患者T淋巴细胞亚群和红细胞免疫功能变化及介入治疗对其的影响[J]. 山东医药, 2012, 52: 59 ?蛳 61.
[12] Xiong B, Feng G, Luo S, et al. Changes of CD4(+) CD25(+) regulatory T cells in peripheral blood in patients with hepatocellular carcinoma before and after TACE[J]. J Huazhong Univ Sci Technolog Med Sci, 2008, 28: 645 ?蛳 648.
[13] 倪全法, 王晓光, 陈徐艰, 等. 肝癌患者肝动脉化疗栓塞术后细胞免疫功能的动态变化及其临床意义[J]. 中国药物与临床, 2011, 11: 906 ?蛳 907.
[14] Wolfraim LA, Takahara M, Viley AM, et al. Clinical scale electroloading of mature dendritic cells with melanoma whole tumor cell lysate is superior to conventional lysate co?蛳 incubation in triggering robust in vitro expansion of functional antigen?蛳 specific CTL[J]. Int Immunopharmacol, 2013, 15: 488 ?蛳 497.
[15] 曹 玮, 万 毅, 张洪新, 等. 热化疗栓塞影响中晚期肝癌患者机体免疫功能的研究[J]. 中国医师杂志, 2009, 11: 176 ?蛳 178.
[16] 廖 娟, 王春晖, 李 肖, 等. 经导管肝动脉化疗栓塞术对原发性肝癌患者细胞免疫及调节T细胞的影响[J]. 肝脏, 2011, 16: 198 ?蛳 201.
[17] Joffre OP, Segura E, Savina A, et al. Cross?蛳 presentation by dendritic cells[J]. Nat Rev Immunol, 2012, 12: 557 ?蛳 569.
[18] Nakamoto Y, Kaneko S. Dendritic cell?蛳 based immunotherapy for hepatocellular carcinoma[J]. Gan To Kagaku Ryoho, 2010, 37: 413 ?蛳 416.
[19] Nagai H, Mukozu T, Matsui D, et al. Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma[J]. Clin Dev Immunol, 2012: 607851.
[20] Yu X, Xia W, Zhang T, et al. Enhanced cytotoxicity of IL?蛳 24 gene?蛳 modified dendritic cells co?蛳 cultured with cytokine?蛳 induced killer cells to hepatocellular carcinoma cells[J]. Int J Hematol, 2010, 92: 276 ?蛳 282.
[21] Basu S, Bimder RJ, Suto R, et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver apartial maturation signal to dendritic cells and activate the NF?蛳 κB path?蛳 way[J]. Immumology, 2000, 12: 1539 ?蛳 1546.
[22] Ninomiya T, Akbar SM, Masumoto T, et al. Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma[J]. J Hepatol, 1999, 31: 323 ?蛳 331.
[23] Ma J, Usui Y, Takeuchi M, et al. Human uveal melanoma cells inhibit the immunostimulatory function of dendritic cells[J]. Exp Eye Res, 2010, 91: 491 ?蛳 499.
[24] 王广伟, 顾元龙, 刘敏丰. 负载自身肿瘤裂解物的树突状细胞联合杀伤细胞对肝癌患者术后免疫功能的影响[J]. 中华普通外科杂志, 2012, 27: 337 ?蛳 338.
[25] 张 浩, 郑树森, 蒋国平, 等. 小鼠肝癌树突状细胞融合瘤苗抗肿瘤作用的研究[J]. 中华肝脏病杂志, 2004, 12: 648 ?蛳 651.
[26] 栾智勇, 陈复兴, 徐永茂, 等. 超声引导下肝癌瘤体内注射抗肿瘤免疫效应细胞的临床研究[J]. 中国超声医学杂志, 2012, 28: 395 ?蛳 398.
[27] 杜文贞, 于天霞. 重组腺相关病毒转导人树突状细胞体外诱导抗肝癌免疫应答[J]. 中华医学杂志, 2011, 91: 2077 ?蛳 2080.
[28] Michiels A, Breckpot K, Corthals J, et al. Induction of antigen?蛳 specific CD8+ cytotoxic T cells by dendritic cells co?蛳 electropo?蛳rated with a dsRNA analogue and tumor antigen mRNA[J]. Gene Ther, 2006, 13: 1027 ?蛳 1036.
[29] Nakamoto Y, Mizukoshi E, Tsuji H, et al. Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety[J]. Clin Exp Immunol, 2007, 147: 296 ?蛳 305.
[30] 张 扬, 谭 岩, 刘 冰. DC?蛳 CIK细胞治疗联合微创介入治疗原发性肝癌的临床研究[J]. 中国实用医药, 2012, 7: 103 ?蛳 104.
[31] 许 伟, 徐 浩, 陈复兴, 等. TACE联合树突状细胞、 γδT细胞治疗HCC患者的细胞免疫功能变化[J]. 徐州医学院学报, 2008, 28: 694 ?蛳 697.
[32] 王福立. 肝癌细胞抗原致敏的DC?蛳 CIK联合TACE治疗原发性肝癌的临床研究[D]. 济南: 山东大学, 2011: 1 ?蛳 52.
[33] Nakamoto Y, Mizukoshi E, Kitahara M, et al. Prolonged recurrence?蛳 free survival following OK432?蛳 stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization[J]. Clin Exp Immunol, 2011, 163: 165 ?蛳 177.
[34] Schmidt N, Büttner N, Thimme R. Perspectives on immunotherapy for hepatocellular carcinoma[J]. Dtsch Med Wochenschr, 2013, 138: 740 ?蛳 744. 

相似文献/References:

[1]张 琳,黄学全,王健,等.自主研发电化学治疗同轴电极与传统针式电极电解效应的对比研究[J].介入放射学杂志,2012,(02):148.
 ZHANG Lin,HUANG Xue-quan,WANG Jian,et al.The electrolytic effect in electrochemotherapy: a comparative study between self-prepared coaxial electrode and conventional needle electrode[J].journal interventional radiology,2012,(02):148.
[2]赵 玮,王伟中,陈莹,等.耳部动静脉畸形供血动脉的血管造影研究[J].介入放射学杂志,2012,(02):103.
 ZHAO Wei,WANG Wei-zhong,CHEN Ying,et al.Angiographic findings of the feeding arteries of auricular arteriovenous malformations[J].journal interventional radiology,2012,(02):103.
[3]邹俊民,龙世娟,张振明. 改良髂内动脉化疗联合放疗治疗Ⅲ~Ⅳa期 子宫颈癌32例[J].介入放射学杂志,2012,(02):123.
 ZOU Jun-min,LONG Shi-Juan,ZHANG Zheng-ming..Improved internal iliac artery chemotherapy combined with radiotherapy for the treatment of stage Ⅲ-Ⅳa cervical cancers[J].journal interventional radiology,2012,(02):123.
[4]王昌明,李 选,宋世兵,等.肝门部胆道引流管折叠技术在肝移植后胆道非吻合口狭窄治疗中的应用[J].介入放射学杂志,2012,(02):136.
 WANG Chang-ming,LI Xuan,SONG Shi-bing,et al.The application of biliary catheter folding technique in the treatment of hilar nonanastomotic biliary strictures after orthotopic liver transplantation[J].journal interventional radiology,2012,(02):136.
[5]赵玉峰,孙玉琴,韩晓静,等. 输卵管介入再通术后受孕时机的研究[J].介入放射学杂志,2012,(02):158.
 ZHAO Yu-feng,SUN Yu-qin,HAN Xiao-jing,et al.The optimal time for conception after fallopian tube recanalization therapy[J].journal interventional radiology,2012,(02):158.
[6]含 笑,曹建民,史东宏,等.吉西他滨、顺铂动静脉联合化疗治疗晚期非小细胞肺癌的近期疗效分析[J].介入放射学杂志,2012,(02):119.
 HAN Xiao,CAO Jian-min,SHI Dong-hong,et al.Bronchial artery infusion of Gemcitabine and Cisplatin combined with systemic chemotherapy for advanced non-small cell lung cancer: its short-term efficacy[J].journal interventional radiology,2012,(02):119.
[7]姚雪松,李 槐.不可手术切除的肝细胞癌的疗效评价标准——改良RECIST标准更可靠[J].介入放射学杂志,2012,(03):177.
 . Therapeutic evaluation criterion of inoperable hepatocellular carcinomas: modified RECIST as a more reliable standard[J].journal interventional radiology,2012,(02):177.
[8]齐 立,李慎茂,俸军林,等. 动脉溶栓与机械碎栓联合动脉溶栓的对比分析[J].介入放射学杂志,2012,(03):180.
 ,,et al. Comparison of the therapeutic efficacy between simple arterial thrombolysis and mechanical thrombectomy combined with arterial thrombolysis for acute cerebral infarction at its ultraearly stage[J].journal interventional radiology,2012,(02):180.
[9]石 潆,赵 卫,沈 进,等.脑动静脉畸形栓塞治疗术并发颅内出血的原因及处理[J].介入放射学杂志,2012,(03):185.
 ,,et al.Intracranial hemorrhage due to embolization therapy for cerebral arteriovenous malformation: its causes and management [J].journal interventional radiology,2012,(02):185.
[10]周 慷,李晓光,金征宇,等.清宫术前子宫动脉化疗栓塞术治疗瘢痕妊娠的疗效分析[J].介入放射学杂志,2012,(03):190.
 ,,et al.Therapeutic analysis of bilateral uterine artery chemoembolization performed before uterine dilation and curettage for cesarean scar pregnancy [J].journal interventional radiology,2012,(02):190.

备注/Memo

备注/Memo:
 (收稿日期:2013-06-27)
更新日期/Last Update: